Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Profit After Tax

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit After Tax ₹528 Cr₹562 Cr₹703 Cr₹419 Cr₹101 Cr

What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?

The latest Profit After Tax ratio of EMCURE PHARMACEUTICALS is ₹528 Cr based on Mar2024 Consolidated results.
Year Profit After Tax
Mar2024₹528 Cr
Mar2023₹562 Cr
Mar2022₹703 Cr
Mar2021₹419 Cr
Mar2020₹101 Cr

How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?

Years Profit After Tax % Change
Mar2024 ₹528 Cr
-6.10
Mar2023 ₹562 Cr
-20.03
Mar2022 ₹703 Cr
67.84
Mar2021 ₹419 Cr
316.06
Mar2020 ₹101 Cr -

Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹18,700.8 Cr -8% 4.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,142.0 Cr -1.5% 9.1% 9.1% Stock Analytics
DIVIS LABORATORIES ₹145,762.0 Cr -4.9% -0.6% 59.1% Stock Analytics
CIPLA ₹114,322.0 Cr -1.8% 1% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,171.0 Cr 1.6% 12.1% 21.8% Stock Analytics
DR REDDYS LABORATORIES ₹92,603.7 Cr -3% -0.9% -7.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-8%

4.7%

NA
SENSEX

-2.9%

3.1%

1.8%


You may also like the below Video Courses